Staar Surgical Co expects a delay in approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its Visian Toric ICL, its implantable lens to treat myopia and astigmatism. The PMDA has, however, not sought any more clinical trials for Visian Toric ICL. The company’s Visian ICL products are, however, on a “very quick path” to approval in the country. Visian ICL (Implantable Collamer Lens) is used to treat myopia or nearsightedness.

A study showed that posterior chamber phakic IOL implantation treated myopia and astigmatism in patients who underwent previous penetrating keratoplasty (PK). The prospective study included 15 eyes of 15 patients with a mean age of 37.8 years who underwent previous PK and were unable to wear spectacles or contact lenses or to undergo corneal refractive surgery.